Printer Friendly
The Free Library
22,725,466 articles and books

An ominous report published in the New England Journal of Medicine suggests that gonorrhea is becoming increasingly resistant to antibiotic treatment..

* An ominous report published in the New England Journal of Medicine The New England Journal of Medicine (New Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world.  suggests that gonorrhea is becoming increasingly resistant to antibiotic treatment. For the last few years, an increasing number of cases of the sexually transmitted disease sexually transmitted disease (STD) or venereal disease, term for infections acquired mainly through sexual contact. Five diseases were traditionally known as venereal diseases: gonorrhea, syphilis, and the less common granuloma inguinale,  have not responded to the conventional last-line treatment which uses cephalosporins. Investigators writing in NEJM NEJM New England Journal of Medicine  have expressed concern that one of humanity's ancient bacterial enemies may soon have to be considered untreatable. This news of gonorrheal antibiotic resistance follows closely on reports of the identification of a strain of e.colibacteria with drug-resistant genes, pneumonia that has developed resistance to antibiotics of last resort called carbapenems, and unconfirmed reports of untreatable cases of tuberculosis in India.
COPYRIGHT 2012 NP Communications, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

 Reader Opinion




Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Infectious Diseases
Publication:Medical Laboratory Observer
Article Type:Brief article
Geographic Code:4EUUK
Date:Mar 1, 2012
Previous Article:Genomic Health study shows positive result of new colon cancer RS test.
Next Article:Analytical Challenges For Forensic Screening of Drugs of Abuse.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters